hacktheripper@hushmail.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TTXI is anyone holding this POS or is the run over?
AMEP SPread .067 x .075
News is a cummin........
TTXI buying starting to come back in em.
WLDI
100 sale means MM needs shares
200 sale means MM needs shares bad-lot of orders he cannot cover
300 sale means MM is going to take price down to get shares
400 sale means trade sideways
500 sale gapping up or down depending on which way the sale went
WLDI 100 share buy above ask????
Getting complaints I bet...
WLDI
Setting up the run right now.... Hold on probably close above .009 today
WLDI Here comes the shake...
WLDI in at .0068
CYGX I don't know what your screens say... but i looks like the asks have move out...
I don't see really any resistance until 1.19 - 1.20 level...
Hopefully HOD close
CYGX MM's loading up more here they tried to drive price down but there is no selling....
HAHAHAH
One finger salute to the MM's
Anyone still holding TTXI?
Opinions....Please
CYGX who is waiting for this afternoon 1.03 now
Take it easy Dallas its your first day back...
CYGX accumulation going on... Expect a good afternoon run..
CYGX making another run holding .99
I got ETURD to work...
I spoke to a rep from ETURD and confirmed their system is down...
They said it should be back up in 15 minutes from 10:24 Eastern.
You will have to completely log off ETURD then relog on b4 you can get your portfolio data...
Ohhh how I luv ETURD...
Anyone having problems with ETURD???
Glad to have you back Monk...
Missed ya
TTXI dead in the water.... 3300 shares traded?
CYGX.... I did not even see .90.... it went by so fast..
CYGX Stack em' Pack em' and Rack em' on the buy side...
Ask is clearing out... Looking for a good run today...
We break .90 today and its off to the races....
AGRD Premarket trading????
us;AGRD AuGRID Corp Common Stock
+ 0.0110 Unch H 0 L 0 V 50,000 17-Sep-03
Price Vol Exc Time ActMMID
0.0115 500 (U) 8.56.18T
INCR NEWS
Incara Pharmaceuticals Signs $5 Million Financing Agreement
/FROM PR NEWSWIRE CHARLOTTE 704-338-9366/
TO BUSINESS AND MEDICAL EDITORS:
Incara Pharmaceuticals Signs $5 Million Financing Agreement
RESEARCH TRIANGLE PARK, N.C., Sept. 17 /PRNewswire-FirstCall/ -- Incara
Pharmaceuticals Corporation (OTC Bulletin Board: INCR) announced today that it
has signed a $5 million Debenture and Warrant Purchase Agreement with Goodnow
Capital, L.L.C., an investment entity controlled by the Xmark Funds. This
purchase agreement follows an earlier $3 million commitment of bridge funding
from Goodnow to Incara that was announced in July 2003, at which time a
nonbinding letter of intent for this additional $5 million financing was
announced. Among other conditions, the $5 million financing is subject to
Incara's completion of a reorganizational merger and satisfactory completion
of a toxicology study relating to Incara's catalytic antioxidant compounds.
The $5 million second financing will be in the form of a debenture or
warrants that are exercisable at the option of the investors into common stock
of the merged company at $.10 per share and is secured by the assets of Incara
and its subsidiaries. The issuance of common stock for the debenture, the
warrants and the $3 million bridge note will not exceed 80 million total
shares, plus common stock that will be issued for interest on the debenture
and the bridge note. The proceeds of each of these financing transactions are
to be advanced to the company over time according to a pre-approved budget.
In connection with the financings, Incara will seek stockholder approval
to combine with its subsidiary in a reorganizational merger in which the
subsidiary will be the surviving entity and be renamed Incara Pharmaceuticals
Corporation. Incara common stock will be converted into common stock of the
surviving company and will continue to trade as Incara Pharmaceuticals
Corporation. The merger also will result in the conversion of the $3 million
bridge loan into common stock of the surviving company at $.10 per share,
conversion of Incara's current Series B preferred stock into nonvoting common
stock equivalent shares of the surviving company and conversion of Incara's
current Series C preferred stock into common stock of the surviving company.
The reorganizational merger is intended to be tax free to Incara's
stockholders. The merger is subject to the approval of Incara stockholders
and other customary conditions.
Completion of these two financings, totaling $8 million, is expected to
provide sufficient funds to complete a Phase 1 clinical trial for AEOL 10150,
a catalytic antioxidant compound that Incara intends to develop for treatment
of amyotrophic lateral sclerosis (Lou Gehrig's disease).
Incara Pharmaceuticals Corporation is developing a new class of small
molecule catalytic antioxidants that destroy oxygen-derived free radicals,
believed to be an important contributor to the pathogenesis of many diseases.
Incara's catalytic antioxidants have been shown to reduce damage to tissue in
animal studies of neurological disorders such as amyotrophic lateral sclerosis
and stroke, and in other non-neurological indications such as cancer radiation
therapy, chronic bronchitis and asthma. Incara has completed pharmacology
studies, selected a first indication for clinical development, conducted
preliminary dose ranging toxicology studies and completed scale-up synthesis
of its lead molecule.
The statements in this press release that are not purely statements of
historical fact are forward-looking statements, and actual results might
differ materially from those anticipated. These statements and other
statements made elsewhere by Incara or its representatives, which are
identified or qualified by words such as "intends," "likely," "will,"
"suggests," "expects," "might," "may," "believe," "could," "should," "would,"
"anticipates," "plans," or the negative of those terms or similar expressions,
are based on a number of assumptions that are subject to risks and
uncertainties. Important factors that could cause results to differ include
risks associated with the need to conserve and obtain funds for operations,
and the uncertainties of clinical trials, product development activities and
scientific research. These and other important risks are described in
Incara's reports on Form 10-K, Form 10-Q and Form 8-K and its registration
statements filed with the Securities and Exchange Commission. Readers are
cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date hereof. Incara assumes no obligation to
update the information in this release.
SOURCE Incara Pharmaceuticals Corporation
AMEP come on need some good news cash is just sitting there....
Sounds like the crooks are monitoring the crooks now..
Maybe we can get Martha Stewart to head this up...
Read if you invested in Polaroid
Schatz & Nobel, P.C. Announces Class Action Lawsuit on Behalf of Purchasers of Polaroid Corporation Stock
/FROM PR NEWSWIRE BOSTON 617-482-5355/
TO BUSINESS EDITOR:
Schatz & Nobel, P.C. Announces Class Action Lawsuit on Behalf of Purchasers of
Polaroid Corporation Stock
HARTFORD, Conn., Sept. 16 /PRNewswire/ -- A lawsuit seeking class action
status has been filed in the United States District Court for the Southern
District of New York on behalf of all persons who purchased the common stock
of Polaroid Corporation (formerly NYSE: PRD currently OTC: PRDCQ.PK)
("Polaroid" or the "Company") from January 26, 2000 through August 9, 2001,
inclusive (the "Class Period").
Plaintiffs are represented by the law firm of Schatz & Nobel, P.C., which
has significant experience prosecuting class actions on behalf of investors.
If you wish to discuss this action or have any questions, please contact
attorneys Andrew M. Schatz or Nancy A. Kulesa at (800) 797-5499, or by e-mail
at sn06106@aol.com. For more information about Schatz & Nobel, P.C. and class
action cases, please visit our website: www.snlaw.net.
The Complaint alleges that KPMG and certain of Polaroid's officers and
directors issued materially false and misleading statements concerning the
Company's financial condition. KPMG, Polaroid's auditor, also issued
unqualified audit opinions regarding Polaroid's financial statements during
the Class Period. As was belatedly disclosed in a report issued by the
Examiner appointed in connection with the Polaroid bankruptcy proceeding,
defendants' financial statements issued throughout the Class Period were
materially false and misleading because defendants knew or should have known
that Polaroid's financial condition had significantly deteriorated and was
much more severe than was being represented to the public.
Plaintiffs seek to recover damages on behalf of all Class Members. If you
purchased or otherwise acquired Polaroid from January 26, 2000 through August
9, 2001 inclusive, and wish to act as a lead plaintiff, you may move the Court
to act in that capacity not later than October 27, 2003. If you wish to
discuss your rights as lead plaintiff or as a class member, please contact
Schatz & Nobel, P.C. toll-free at (800) 797-5499, or by e-mail at
sn06106@aol.com.
CONTACT: Nancy A. Kulesa
Tel.: (800) 797-5499
Website: www.snlaw.net
e-mail: sn06106@aol.com
SOURCE Polaroid Corporation
/CONTACT: Nancy A. Kulesa of Schatz & Nobel, P.C.,
+1-800-797-5499,sn06106@aol.com/
/Web site: http://www.snlaw.net/
Sep-16-2003 22:37 GMT
Symbols:
CA;PRDCQ US;PRDCQ
Source PRN PR Newswire
Categories:
ISABEL last guess will hit north carolina with 105MPH winds...
CYGX probably add another 10% tomorrow
Hope so... hold shares
With the gains CYGX has made lately... do you think that when news is out the MM's will walk it back down...
CYGX now setting up for run MM's moving out
TTXI In at .061
isn't that a shame... when you have to hold for a whole two weeks for a double...
Tell that to all those folks who are getting .0127 percent on their CD's .... LOL
they will be selling those shares when it gets above a 1.00
thanks em
What website ru using for real time scans?
AMEP This is the longest 2 weeks I have ever seen in waiting for their annoucement.
They make dollars out of those charts....